The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses

Immunology

Volumn 96, Issue 3, 1999, Pages 411-415

  Micheletti, F ^a   Bazzaro, M ^a   Canella, A ^a   Marastoni, M ^a   Traniello, S ^a   Gavioli, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CRYSTALLOGRAPHY; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HYDROGEN BOND; IMMUNOGENICITY; IMMUNOSTIMULATION; LIFESPAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL;

CELL CULTURE TECHNIQUES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HALF-LIFE; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033020741     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00707.x     Document Type: Article

References (24)

1. SAPER M.A., BJORKMAN P.J. & WILEY D.C. (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol 219, 277.
2. FALK K., RÖTZSCHKE O., STEVANOVIC S., JUNG G. & RAMMENSEE H.-G. (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond) 351, 290.
3. TOWNSEND A.R.M., ÖLEN C., BASTIN J., LJUNGGREN H.G., FOSTER L. & KÄRRE K. (1989) Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature (Lond) 340, 443.
4. LJUNGGREN H.-G., STAM N.J., ÖHLEN C. et al. (1990) Empty MHC class I molecules come out in the cold. Nature (Lond) 346, 476.
5. GARRETT T.P.J., SAPER M.A., BJORKMAN P.J., STROMINGER J.L. & WILEY D.C. (1989) Specificity pockets for the side chains of peptide antigens in HLA Aw68. Nature (Lond) 342, 692.
6. MADDEN D.R., GARBOCZI D.N. & WILEY D.C. (1993) The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75, 693.
7. SAITO Y., PETERSON P.A. & MATSUMURA M. (1993) Quantitation of peptide residue contributions to class I major histocompatibility complex molecule binding. J Biol Chem 268, 21309.
8. NEEFJES J.J., DIERX J. & PLOEGH H.L. (1993) The effect of anchor residue modifications on the stability of major histocompatibility complex class I-peptide interactions. Eur J Immunol 23, 840.
9. + population. Science 260, 98.
10. DE CAMPOS-LIMA P.O., LEVITSKY V., BROOKS J., LEE S.P., HU L.F., RICKINSON A.B. & MASUCCI M.G. (1994) T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J Exp Med 179, 1297.
11. ZHANG Q.-J., GAVIOLI R., KLEIN G. & MASUCCI M.G. (1993) An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc Natl Acad Sci USA 90, 2217.
12. GAVIOLI R., ZHANG Q.-J., MARASTONI M. et al. (1995) Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes. Biochem Biophys Res Commun 206, 8.
13. GAVIOLI R., GUERRINI R., MASUCCI M.G., TOMATIS R., TRANIELLO S. & MARASTONI M. (1998) High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/pcptide complexes. FEBS Lett 421, 95.
14. SETTE A., VITTIELLO A., REHERMAN B. et al. (1994) The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153, 5586.
15. VAN DER BURG S.H., VISSEREN M.J.W., BRANDT R.M.P., KAST W.M. & MELIEF C.J.M. (1996) Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol 156, 3308.
16. CHEN W., KHILKO S., FECONDO J., MARGULIES D.H. & MCCLUSKEY J. (1994) Determinant selection of major histocompatibilily complex class I-restricted antigenic peptides is explained by class I-peptide affinity an is strongly influenced by nondominant anchor residues. J Exp Med 180, 1471.
17. GAVIOLI R., KURILLA M., DE CAMPOS-LIMA P.O. et al. (1993) Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol 67, 1572.
18. SALTER R.D. & CRESSWELL P. (1986) Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 5, 943.
19. MASUCCI M.G., ZHANG Q.-J., GAVIOLI R. et al. (1992) Immune escape by Epstein Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV specific cytotoxic T cells. Int Immunol 4, 1282.
20. ZHANG Q.-J., LINDQUIST Y., LEVITSKY V. & MASUCCI M.G. (1996) Solvent exposed side chains of peptides bound to HLA*A1101 have similar effects on the reactivity of alloantibodies and specific TCR. Int Immunol 8, 927.
21. GAVIOLI R., DE CAMPOS-LIMA P.O., KURILLA M.G., KIEFF E., KLEIN G. & MASUCCI M.G. (1992) Recognition of the EBV encoded nuclear antigens EBNA-4 and EBNA-6 by HLA A11 restricted cytotoxic T-lymphocytes. Implications for the down-regulation of HLA A11 in Burkitt's lymphoma. Proc Natl Acad Sci USA 89, 5862.
22. REALI E., GUERRINI R., GIORI B. et al. (1996) Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides. Clin Exp Immunol 105, 369.
23. POGUE R.R., ERON J., FRELINGER J.A. & MATSUI M. (1995) Amino-terminal alteration of the HLA-A0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc Natl Acad Sci USA 92, 8166.
24. TOURDOT S., OUKKA M., MANUGUERRA J.C. et al. (1997) Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity. J Immunol 159, 2391.